Insights

Innovative Focus Cure Ventures specializes in building companies around groundbreaking curative technologies targeting high unmet patient needs, presenting opportunities to partner with biotech firms and pharmaceutical companies seeking disruptive scientific solutions.

Active Investments Recent investments in Tasca Therapeutics and Kenai Therapeutics showcase Cure Ventures’ commitment to funding early-stage biotech companies, indicating potential openings for collaborative ventures, co-investments, or service offerings in biotech fundraising.

Collaborative Network The firm’s co-investors include major players like Regeneron, Invus Group, and Alaska Permanent Fund, highlighting a strong network of influential biotech and investment partners that can be leveraged for strategic alliances or joint business development opportunities.

Scientifically Driven Cure Ventures emphasizes rigorous scientific validation, large uncrowded markets, and expedited clinical routes, signaling a need for advanced research tools, specialized scientific services, and consulting firms to support biotech startups through clinical development stages.

Market Potential With a revenue range of 10 to 25 million dollars and a focus on high-impact biotech innovations, there is significant potential for sales in areas such as biotech infrastructure, clinical trial support, regulatory consulting, and precision medicine technologies targeting the biotech sector.

Cure Ventures Tech Stack

Cure Ventures uses 8 technology products and services including MySQL, Apple iCloud Mail, Font Awesome, and more. Explore Cure Ventures's tech stack below.

  • MySQL
    Database
  • Apple iCloud Mail
    Email
  • Font Awesome
    Font Scripts
  • JSON-LD
    Javascript Frameworks
  • Infinite Scroll
    Javascript Libraries
  • Priority Hints
    Performance
  • Ionicons
    Web Fonts
  • Formidable Forms
    Web Platform Extensions

Cure Ventures's Email Address Formats

Cure Ventures uses at least 1 format(s):
Cure Ventures Email FormatsExamplePercentage
FLast@curevc.comJDoe@curevc.com
45%
First.Last@curevc.comJohn.Doe@curevc.com
5%
FLast@curevc.comJDoe@curevc.com
45%
First.Last@curevc.comJohn.Doe@curevc.com
5%

Frequently Asked Questions

Where is Cure Ventures's headquarters located?

Minus sign iconPlus sign icon
Cure Ventures's main headquarters is located at Boston, Massachusetts 02210 United States. The company has employees across 1 continents, including North America.

What is Cure Ventures's official website and social media links?

Minus sign iconPlus sign icon
Cure Ventures's official website is curevc.com and has social profiles on LinkedIn.

What is Cure Ventures's NAICS code?

Minus sign iconPlus sign icon
Cure Ventures's NAICS code is 52391 - Miscellaneous Intermediation.

How many employees does Cure Ventures have currently?

Minus sign iconPlus sign icon
As of April 2026, Cure Ventures has approximately 18 employees across 1 continents, including North America. Key team members include Chief Technology Officer, Partner: B. A.Managing Partner And Co-Founder: L. T.Managing Partner And Co-Founder: R. L.. Explore Cure Ventures's employee directory with LeadIQ.

What industry does Cure Ventures belong to?

Minus sign iconPlus sign icon
Cure Ventures operates in the Venture Capital and Private Equity Principals industry.

What technology does Cure Ventures use?

Minus sign iconPlus sign icon
Cure Ventures's tech stack includes MySQLApple iCloud MailFont AwesomeJSON-LDInfinite ScrollPriority HintsIoniconsFormidable Forms.

What is Cure Ventures's email format?

Minus sign iconPlus sign icon
Cure Ventures's email format typically follows the pattern of FLast@curevc.com. Find more Cure Ventures email formats with LeadIQ.

When was Cure Ventures founded?

Minus sign iconPlus sign icon
Cure Ventures was founded in 2020.

Cure Ventures

Venture Capital and Private Equity PrincipalsMassachusetts, United States11-50 Employees

Cure Ventures is a venture capital firm focusing on company formation around groundbreaking curative technologies.

Cure Ventures harnesses our team's skills and decades of company-building experience to create innovative companies that aim to eradicate diseases by focusing on de novo company formation built around bold ideas and visionary entrepreneurs. 

We provide the right level of human and financial capital that is required at each stage of the company's life. We seek to build great companies around pioneering scientific solutions with strong intellectual property positions. The Cure Ventures team focuses on disruptive technologies that target high unmet patient needs.

The optimal company build will exhibit a clear genetic validation, substantiated and rigorously derived scientific data, the provenance of a distinguished scientific laboratory, biology with mechanistic clarity, multiple commercial applications, large uncrowded markets, expedited clinical routes, string partnering interest from large pharmaceutical companies, and an articulable oath to an exit.

Section iconCompany Overview

Headquarters
Boston, Massachusetts 02210 United States
Website
curevc.com
NAICS Code
52391 - Miscellaneous Intermediation
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $10M$25M

    Cure Ventures's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Cure Ventures's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.